MedTrace Logo

Vitamin D Supplementation and TB

NCT01992263 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 200

Last updated 2020-09-09

No results posted yet for this study

Summary

The goal of this study is to understand the effects of vitamin D supplementation on immunological outcomes among patients with tuberculosis.

Conditions

Interventions

DIETARY_SUPPLEMENT

Vitamin D (600 IU)

Daily oral dose for 12 months

DIETARY_SUPPLEMENT

Vitamin D (2000 IU)

Daily oral dose for 12 months

DIETARY_SUPPLEMENT

Vitamin D (4000 IU)

Daily oral dose for 12 months

OTHER

Placebo

Daily oral dose for 12 months

Sponsors & Collaborators

Principal Investigators

  • Saurabh Mehta, MBBS, ScD · Cornell University (U.S.)

  • Wesley Bonam, BSc, MBBS, FAIMS, MRSH · Arogyavaram Medical Centre (India)

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-30
Primary Completion
2022-09-30
Completion
2023-02-28

Countries

  • United States
  • India

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01992263 on ClinicalTrials.gov